Pleural Biopsy Market Size, Share, and Growth Analysis, By Biopsy Techniques (CT-guided Biopsy, Ultrasound-guided Biopsy), By Product Types (Biopsy Needles, Biopsy Kits), By Applications, By End Users, By Region - Industry Forecast 2026-2033

Global Pleural Biopsy Market size was valued at USD 330.4 Million in 2024 and is poised to grow from USD 350.88 Million in 2025 to USD 567.75 Million by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global pleural biopsy market encompasses instruments, consumables, and services aimed at extracting tissue from the pleural space for histopathological and molecular analysis, pivotal for diagnosing conditions like malignant pleural effusion, tuberculosis, and mesothelioma. The rising prevalence of these diseases and a shift towards minimally invasive techniques drive market growth. Clinicians increasingly adopt CT-guided core biopsies and thoracoscopic approaches for enhanced diagnostic precision. Technological advancements, including cryobiopsy and superior imaging, facilitate personalized treatment options, thereby heightening demand for quality pleural tissue. Furthermore, artificial intelligence enhances diagnostic accuracy through automated image analysis, guiding needle placement, and optimizing slide interpretation. This evolution in diagnostics, alongside unmet needs in emerging markets, fosters new commercial opportunities and strategic collaborations for suppliers in this dynamic healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pleural Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pleural Biopsy Market Segments Analysis

Global pleural biopsy market is segmented by biopsy techniques, product types, applications, end users and region. Based on biopsy techniques, the market is segmented into CT-guided Biopsy, Ultrasound-guided Biopsy and Bronchoscopy-assisted Biopsy. Based on product types, the market is segmented into Biopsy Needles, Biopsy Kits and Forceps. Based on applications, the market is segmented into Cancer Diagnosis and Infection Assessment. Based on end users, the market is segmented into Hospitals, Diagnostic Laboratories and Outpatient Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pleural Biopsy Market

The Global Pleural Biopsy market is significantly driven by advancements in imaging and navigation technologies, which have markedly improved the precision of locating pleural lesions and guiding biopsy procedures. This surge in accuracy diminishes uncertainties during biopsies, thereby enhancing clinician confidence. Consequently, these innovations allow for more targeted approaches, particularly for small or challenging lesions while promoting minimally invasive techniques that enhance safety and reproducibility across various treatment centers. Furthermore, improved visualization encourages greater adoption among interventional pulmonologists and thoracic surgeons, stimulates investment in complementary biopsy instruments, and fosters the integration of multimodal workflows, ultimately elevating the demand for pleural biopsy solutions.

Restraints in the Global Pleural Biopsy Market

The Global Pleural Biopsy market faces significant challenges due to insufficient reimbursement policies and elevated procedural costs, which hinder the widespread adoption of biopsy technologies. These financial barriers discourage healthcare institutions from making necessary investments and diminish the routine use of such procedures, especially in environments where profit margins are limited. The uncertainty surrounding costs can lead to delayed procurement processes, restricting opportunities for capital allocation towards training and equipment. Additionally, providers with limited budgets may prefer conservative treatment options or refer patients to specialized centers, ultimately impacting market growth and slowing the integration of innovative biopsy devices across various healthcare environments.

Market Trends of the Global Pleural Biopsy Market

The Global Pleural Biopsy market is witnessing a significant shift towards minimally invasive techniques, as healthcare providers prioritize patient comfort and faster recovery times. Image-guided core needle and thoracoscopic methods are increasingly favored for their efficiency and reduced discomfort, prompting hospitals to invest in advanced devices that facilitate these procedures. As manufacturers innovate in needle design and imaging technologies, they are also enhancing training programs to ensure seamless integration into clinical practice. This trend not only drives collaboration between device manufacturers and healthcare professionals but also encourages product differentiation, leading to broader adoption and improved diagnostic quality across diverse care environments.